Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

SetPoint Medical closes $30mm Series D

Executive Summary

SetPoint Medical Corp. (bioelectronic therapy for chronic inflammatory diseases) raised $30mm through its Series D financing from returning shareholders New Enterprise Associates, Morgenthaler, Medtronic, Boston Scientific, Topspin Partners, Action Potential Venture Capital, and others. The company will use the funding to advance clinical development of its implantable device for rheumatoid arthritis.
Deal Industry
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies